The first case in South China! She was over half a hundred years old and was born with a “Guangdong heart”

Ms. Wu (pseudonym) discovered heart failure for 9 years,

even lying down and sleeping None,

worse, because of the discovery of antibodies,

She can’t even do a heart transplant.

January 28,

she was in Guangdong Provincial People’s Hospital implanted a

thumb-sized, only 90 grams of the world’s smallest artificial heart,

Feeling well for two months after surgery.

It is reported that

She is the first case of this artificial heart implantation in South China.

“Why is modern medicine so exaggerated?”

On March 29, she returned to the hospital for a review,

exclaimed.

World’s smallest artificial heart implanted

54-year-old woman recovers from “heart disease” after nine years

March 29, sitting In front of the reporter, Ms. Wu was dressed in red and smiled, “It feels good, much more relaxed!” she said. The husband who accompanied her to the review admitted that “unexpectedly”, the “heart disease” in nine years can be resolved at one time.

In 2013, Ms. Wu was going to buy commercial insurance and undergo a physical examination as required. She did not expect to find out “heart disease” – she suffered from three There was cuspid regurgitation and an enlarged heart, and she has been on medication since then.

Until 2021, Ms. Wu’s condition has worsened significantly. After a little movement or activity, she will feel chest tightness, asthma, and palpitations. Take a break to relax. But 5 months ago, the situation became serious.She even coughed up white foamy phlegm, and she couldn’t sleep well. Also swollen!

Ms. Wu, accompanied by her husband, rushed to the Heart Research Institute of Guangdong Provincial People’s Hospital (hereinafter referred to as Provincial Medicine), where she was diagnosed with heart disease. Wu Min, deputy director of transplantation and ventricular assist surgery, saw a doctor in an outpatient clinic and was immediately admitted to the hospital.

The medical records truthfully recorded her condition: chest tightness, increased shortness of breath, coughing up white foamy sputum, and intermittent edema of both lower extremities. Subsequent examination results showed that Ms. Wu had enlarged heart, severe tricuspid regurgitation, ventricular apical thrombus, and moderate pulmonary hypertension.She had reached dilated cardiomyopathy with severe mitral valve End-stage heart failure with reflux.

After a series of treatments including one month of balloon counterpulsation (IABP) for her, the condition did not improve. The team of Huang Jinsong, the administrative deputy director of the Medical Heart Surgery Department, decided: “Immediately prepare for the heart transplant treatment!” To make matters worse, the preoperative examination found that Ms. Wu’s HLA antibody was positive, and even after plasma exchange, it continued to remain negative. This antibody can cause rejection after heart transplantation, which is a contraindication to heart transplantation!

After multidisciplinary consultation and discussion and the patient’s full informed consent, the doctor decided to implant an artificial heart for Ms. Wu. On January 28, Huang Jinsong and Wu Min led the team to successfully implant the Corheart6, the world’s smallest and lightest left ventricular assist device, into a patient.

Artificial Heart Implantation Successfully

After After precise adjustment, the third-generation magnetic levitation heart ran smoothly in the patient’s body, and the hemodynamic data was stable. Only one week after the operation, Ms. Wu was able to move freely, resume training, and was discharged from the hospital smoothly.

Surprise:

“Why is medicine so exaggerated now?”

Ms. Wu still remembers the first time she woke up after surgery. Feeling – thinking, “It’s good, I’m still alive!” Then I heard the voices of the doctors saying: “The heart has shrunk significantly”, it was just heavenly!

A week later, she was active in bed, and two weeks later, she got out of bed for a walk. Her husband kept watching Ms. Wu smile with his own eyes, and he felt a little relieved. He can fully appreciate his wife’s happiness. You know, before the operation, she couldn’t even lie down and sleep. She went to the ICU many times. After the operation, she was able to get out of bed and walk. Before the breathing training, she couldn’t blow a single ball. Three balls can be blown up.

Before returning to the provincial medical examination, in her hometown, Ms. Wu could not only go downstairs to exercise, but even walk slowly and go to the market to buy vegetables . Previously, her illness had left her with ischemia, hypoxia, and edema, and she couldn’t speak loudly. “It’s okay to quarrel now!” The husband said that the two of them lived together without the child. It was a great feeling of vitality. .

Ms. Wu has been listening to her husband with a smile, “He is looking at me a little bit, and I am still immersed in surprises. ——Oh my god, why is medicine so exaggerated now?”

Ms.Yan, I had never heard of a heart transplant before, and then I knew that I couldn’t have a heart transplant. When I was at a loss, I heard that an artificial heart could be replaced. “When I inquired later, I said that I have to keep my shoulder bag with me after the operation, and there are instruments inside.” Ms. Wu was a little resistant at the time and didn’t want to go to school like a child in the future, but at the last look, not only was the artificial heart as small as a thumb, but even the instrument bag had been reduced to a small messenger bag, “I think, I Yes!” She smiled embarrassedly, thankful to have found a new life-sustaining treatment option.

Doctor:

The artificial heart is mainly used in three aspects

In fact, Ms. Wu is not the only lucky one. Before her, the provincial doctor had clinically tested two generations of artificial heart implantation, but both were left ventricular assist devices. The previous artificial heart weights were 210 grams and 180 grams respectively; after Ms. Wu, another patient was also implanted The same ultra-small magnetic levitation centrifugal Corheart6 artificial heart with the world’s smallest and lightest weight was obtained, and even the postoperative review was only one day later than her.

According to its introduction, the artificial heart is currently mainly used in three aspects in clinical practice. More time to wait for a suitable donor; the second is to provide short-term replacement support for patients with acute heart failure, which will be removed after the recovery of cardiac function to avoid heart transplantation; the third is to provide long-term replacement for patients with heart failure, allowing patients to carry artificial hearts for long-term survival .

The use of the third situation is increasing, and Ms. Wu belongs to the third situation.

Doctors say that patients with artificial hearts live no less than a heart transplant, on average.

Technology:

The smallest and lightest in the world

The artificial heart is the most complex and sophisticated medical device and is known as the As the “jewel in the crown of medical devices”, the ultra-small magnetic levitation centrifugal artificial heart implantation was successfully implemented in the Guangdong Provincial People’s Hospital, marking the hospital’s next step in the field of applying artificial hearts to treat heart failure.

“Guangdong Heart”

The reporter also learned that Ms. Wu and the The Corheart6 implantable left ventricular assist device implanted in another patient was completely independently developed by the Guangdong scientific research team.The pump body of this “Guangdong heart” is only 34 mm in diameter and only Measuring 26 mm and weighing only 90 grams, it is currently the world’s smallest and lightest magnetic levitation centrifugal artificial heart.

It adopts uniaxial magnetic levitation technology. During operation, the impeller has no contact with any part of the cavity, which reduces hemolysis reduce the risk of developing blood clots. Currently, this artificial heart is undergoing a prospective, multi-center, single-group clinical evaluation trial.


Source: Guangzhou Daily